Department of General Surgery, St George's University Hospital, London, UK.
Royal College of Surgeon Ireland, Dublin, Ireland.
Breast Cancer. 2020 Jul;27(4):534-566. doi: 10.1007/s12282-020-01076-1. Epub 2020 Mar 12.
The present review evaluated health-related quality of life (HR-QoL) outcomes in surgical breast cancer survivors who received breast reconstruction (BR), breast-conservation surgery (BCS) or mastectomy (M), and whether HR-QoL domains across generic and disease/surgery-specific questionnaires are compatible. Six electronic databases were searched for appropriate observational studies. Standardized scores for different HR-QoL domains in the BR, BCS, and M treatment groups were extracted from each study for the purpose of a meta-analysis. Using Stata version 14.0, a random-effects meta-analysis model was adopted for each outcome variable to estimate the effect size, 95% CI-confidence intervals, and statistical significance. Sixteen of the 18 eligible studies with BR (n = 1474) and BCS (n = 2612) or M (n = 1458) groups were included in the meta-analysis. The BR group exhibited a better physical health (k = 12; 0.1, 95% CI 0.04, 0.24) and body image (k = 12; 0.50, 95% CI 0.10, 0.89) than the M group. However, the two groups exhibited comparable social health (k = 13; 0.1, 95% CI -0.07, 0.37), emotional health (k = 13; -0.08, 95% CI - 0.41, 0.25), global health (k = 7; 0.1, 95% CI - 0.01, 0.27), and sexual health (k =11; 0.2, 95% CI - 0.02,0.57). There was no clear evidence of the superiority of BR to BCS for all the six domains. These results suggest that HR-QoL outcomes in BR and BCS groups are better than the M group. Therefore, women opting for BR or BCS are likely to report fairly better HR-QoL outcomes than M. However, due to the significant heterogeneity observed in most BR versus BCS outcomes, developing a unified questionnaire incorporating both breast/surgery-specific and generic HR-QoL domains is warranted.
本综述评估了接受乳房重建 (BR)、保乳手术 (BCS) 或乳房切除术 (M) 的外科乳腺癌幸存者的健康相关生活质量 (HR-QoL) 结局,以及通用和疾病/手术特异性问卷中的 HR-QoL 域是否兼容。为了进行荟萃分析,从每个研究中提取 BR、BCS 和 M 治疗组不同 HR-QoL 域的标准化评分。使用 Stata 版本 14.0,采用随机效应荟萃分析模型对每个结果变量进行估计,以确定效应大小、95%CI 置信区间和统计学意义。纳入了 18 项合格研究中的 16 项,其中 BR(n=1474)和 BCS(n=2612)或 M(n=1458)组进行了荟萃分析。BR 组在生理健康 (k=12;0.1,95%CI0.04,0.24) 和身体形象 (k=12;0.50,95%CI0.10,0.89) 方面优于 M 组。然而,两组在社会健康 (k=13;0.1,95%CI-0.07,0.37)、情感健康 (k=13;-0.08,95%CI-0.41,0.25)、总体健康 (k=7;0.1,95%CI-0.01,0.27) 和性健康 (k=11;0.2,95%CI-0.02,0.57) 方面表现相当。没有明确的证据表明 BR 在所有六个领域都优于 BCS。这些结果表明,BR 和 BCS 组的 HR-QoL 结局优于 M 组。因此,选择 BR 或 BCS 的女性可能会报告比 M 更好的 HR-QoL 结局。然而,由于大多数 BR 与 BCS 结果观察到的显著异质性,有必要开发一种结合乳房/手术特异性和通用 HR-QoL 域的统一问卷。